Open | $2.070 |
Close | $1.990 |
Volume / Avg. | 170.046K / 288.976K |
Day Range | 1.980 - 2.075 |
52 Wk Range | 1.700 - 5.120 |
Market Cap | $89.795M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 8.72% |
Days to Cover | 17.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cue Biopharma (NASDAQ: CUE) through any online brokerage.
Other companies in Cue Biopharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Eagle Pharmaceuticals (NASDAQ:EGRX) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for Cue Biopharma (NASDAQ: CUE) was reported by Jefferies on Wednesday, March 13, 2024. The analyst firm set a price target for 6.00 expecting CUE to rise to within 12 months (a possible 201.51% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Cue Biopharma (NASDAQ: CUE) is $1.99 last updated March 18, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Cue Biopharma.
Cue Biopharma’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Cue Biopharma.
Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.